Virginia Retirement Systems Et Al Rigel Pharmaceuticals Inc Transaction History

Virginia Retirement Systems Et Al

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 16, 2023	SELL	$1.1 - $12.2 $198,770 - $2.2 Million	-180,700 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$2.36 - $3.57 $35,164 - $53,193	14,900 Added 8.99%	180,700 $479,000
Q3 2021 Oct 21, 2021	BUY	$3.5 - $4.5 $91,000 - $117,000	26,000 Added 18.6%	165,800 $602,000
Q2 2021 Aug 13, 2021	BUY	$3.09 - $4.54 $106,296 - $156,176	34,400 Added 32.64%	139,800 $607,000
Q1 2021 Apr 30, 2021	BUY	$3.35 - $4.93 $353,090 - $519,621	105,400 New	105,400 $360,000

334K

Ticker RIGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 172,836,000
Market Cap $2.81B
Description
Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is ...

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

Stay updated on Virginia Retirement Systems Et Al with notifications on news.